Adverse Event Reporting Rate
1 adverse event report is submitted to the TGA for every 227 COVID-19 vaccine doses administered,
PFIZER
1 adverse event report submitted per 256 doses
ASTRAZENECA
1 adverse event report submitted per 202 doses
TTS (Clots with low platelets)
Current Case Status
CASE RATE: 1 case per 65,789 doses
Myocarditis & Pericarditis
We encourage people to seek medical attention if they experience symptoms that could suggest myocarditis or pericarditis such as of chest pain, shortness of breath and palpitations. Typically these have occurred within seven days of vaccination, and more commonly after the second dose of Comirnaty.
CASE RATE: 1 case per 111,500 doses*
*As the majority of people in Australia vaccinated with Pfizer have only had 1 vaccine dose to date, it would be fair to assume that the case rate will steadily climb as more people get access to their second dose.
Guillain-Barre Syndrome
CASE RATE: 1 case per 96,163 doses
Immune Thrombocytopenia Purpura (ITP)
Link to TGA report:
Comments